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osting by EAbstract An isocratic simple rapid assay has been developed and validated for the determination of
carbamazepine (CBZ) in both solution form and rabbit plasma using propylparaben as an internal
standard. The assay was performed using a l-Bondapak C18 (150 mm · 4.6 mm i.d) with a mobile
phase consisting of methanol and water (50:50), the ﬂow rate was 1 ml/min and UV detection at
285 nm.Themethodwas found to be speciﬁc forCBZ, no interfering peakswere observedwith anover-
all analytical run time of 15 min. Accuracy reported as % recovery were found to be 98.37–100.45%
and 97.53–103.58% for inter-day and intra-day accuracies, respectively. Inter-day precision (reproduc-
ibility) was found to be 0.53–2.75% RSD, while intra-day precision (repeatability) was found to be
1.06–3.7%RSD for the samples studied. The calibration curvewas found to be linear with the equation
y= 0.2847x+ 0.0138, with a correlation coefﬁcient of 0.9999 (R2) over a concentration range of
0.5–40 lg/ml. The limit of quantitation was the lowest concentration. The method is simple and rapid
and does not require any preliminary treatment of the sample. The method was fully validated.
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lsevier1. Introduction
Carbamazepine (CBZ), 5-H-dibenze[b,f]azepine-5-carboxam-
ide (Fig. 1), is a tricyclic lipophilic compound that is a ﬁrst-
choice antiepileptic drug for the treatment of simple and com-
plex partial seizures (Duche and Loiseau, 1995). It is almost
completelymetabolized in the body and only small traces are ex-
creted unchanged in urine (Goodman et al., 2001). Therapeutic
concentrations have been reported to be 6–12 lg/ml, although
considerable variations may arise (Goodman et al., 2001). The
use of an established therapeutic range for CBZ concentration
Figure 1 Chemical structure of carbamazepine and
propylparaben (IS).
30 H.A. Mowafy et al.is limited by the presence of carbamazepine-10,11-epoxide
(CBZ-E), its active metabolite that signiﬁcantly contributes to
the efﬁcacy and toxicity and also possesses pharmacological
activity as an anticonvulsant (He et al., 1992), though it reaches
lower concentrations than CBZ.
Various methods have been reported in the literature for
the determination of CBZ, in particular those using chroma-
tography (Bhatti et al., 1998; Dasgupta et al., 1999; Ashy
et al., 1986; Raggi et al., 2000; Franceschi and Furlanut,
2005; Chelberg et al., 1988; Hartley et al., 1986; Oh et al.,
2006; Yoshida et al., 2006; Elizabeth et al., 2007; Budakova
et al., 2008; Hemenway et al., 2010). High-performance liquid
chromatography (HPLC) and ﬂuorescence polarization immu-
noassay (FPIA) are usually employed as routine techniques for
the determination of this and other anticonvulsants (Sanchez
et al., 1999). Other techniques such as micellar electrokinetic
capillary chromatography (MECC) (Lancas et al., 2003) and
chemiluminescence (Lee et al., 2003) were used. Very recently,
two approaches were presented in the literature. One of them
uses spectrophotometry and multivariate calibration (Rezaei
et al., 2005) for the simultaneous determination of CBZ and
phenytoin. The other method exploits the unusual ﬂuorescence
of CBZ on a nylon membrane (Escandar et al., 2004).
Simultaneous determinations of CBZ and its metabolites in
biological ﬂuids and drug products (Burke and Thenot, 1985;
Owen et al., 2001) have been published, including, solid–liquid
extraction (Wad, 1984), liquid–liquid extraction (Rouan et al.,
1992), column-switching (Juergens, 1984), deproteinization
(Liu et al., 1993), spectroﬂuorimetry method (Huang et al.,
2002), gas–liquid chromatography (Chen and Bashi, 1991),
FT-Raman spectroscopy (Auer et al., 2003), planar chroma-
tography (Mennickent et al., 2009), stir bar-sorptive extraction
and high-performance liquid chromatography-UV detection
(SBSE/HPLC-UV) (Queiroz et al., 2008) and high-perfor-
mance thin layer chromatography (HPTLC) (Patel et al.,
2011). Also, LC–mass spectrometry methods (Breton et al.,2005; Van Rooyen et al., 2002; Miao and Metcalfe, 2003;
Zhu et al., 2005) have been reported for the detection of
CBZ and its metabolites in aquatic environments and in plas-
ma. Only one article that focused on forced degradation of
CBZ used acid, base, oxidation, heat and photolytic condi-
tions. Much degradation was not observed in CBZ samples un-
der stress conditions like acid hydrolysis photolysis and
thermal exposure. However, mild degradation was observed
during alkaline hydrolysis and signiﬁcant degradation was ob-
served when the drug was exposed to oxidation by hydrogen
peroxide (Srinivasa and Belorkar, 2010). There is no article
concerning complete analysis and validation of CBZ in rabbit
plasma, So, the aim of this study was to establish a method
based on HPLC-UV that is capable of analyzing CBZ in both
solution and rabbit plasma in order to facilitate nanotechnol-
ogy studies of CBZ.2. Materials and methods
2.1. Materials
Carbamazepine was kindly supplied by Tabouk Pharmaceuti-
cal Company, Tabouk, Kingdom of Saudi Arabia. Methanol
(HPLC grade) was purchased from BDH, Pool, England.
Water for HPLC was puriﬁed from ELGA PURELAB
UHQ-II-MK3, HP143JH, UK. All other chemicals and
solvents were of analytical reagent grade.
2.2. Equipment and chromatographic conditions
The study employed a high pressure liquid chromatography
(Waters 1515 isocratic controller, Waters, USA) equipped
with a Waters 2487 Dual k Absorbance detector and an auto-
matic sampling system (Waters 717). The mobile phase con-
sisted of methanol and water (50:50), and the ﬂow rate was
1 ml/min. Separation was achieved using a 150 mm · 4.6 mm
(i.d.) C18, l-Bondapak, Waters, reversed phase column with
an average particle size of 10 lm, and the column was kept at
ambient temperature. The column efﬂuent was monitored at
285 nm and the chromatographic data analysis was performed
with the Empower Program (Waters, USA).
2.3. Stocks solutions and standards
Stock solutions of CBZ were prepared in triplicate by dissolv-
ing 50.0 mg CBZ in 50 ml methanol, resulting in a solution
containing 1 mg/ml. This solution was diluted 20-fold by meth-
anol to give working solution (50 lg/ml). A stock solution of
the internal standard at a concentration of 1 mg/ml was pre-
pared by dissolving 50.0 mg of propylparaben (Fig. 1) in
50 ml methanol. Working solutions of CBZ (50 lg/ml), and
250 lg/ml of propylparaben were prepared by dilution of the
stock solutions in methanol.
Calibration curves were constructed in methanol by prepar-
ing a series of concentrations of the drug (0.5, 1, 2, 5, 10, 20
and 40 lg/ml) with the internal standard included at a ﬁxed
concentration of 10 lg/ml.
Calibration curves were also constructed in rabbit plasma.
These involved replicate analysis of plasma samples spiked
with varying concentrations of CBZ (0.5, 1, 2, 5, 10, 20 and
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(10 lg/ml).
2.4. Treatment of plasma samples
The working solutions (100 ll) were separately transferred to
clean dry centrifugation tubes. Rabbit plasma (500 ll) was
added to each tube. These were vortex mixed for 2 min before
adding 400 ll of methanol. These were vortex mixed before
centrifugation at 5000 rpm for 5 min. The supernatant was
separated and loaded into HPLC vials before injecting 50 ll
into the HPLC system.
2.5. Method validation
The calibration curve of CBZ is a plot of the peak area ratio
(PAR) of the drug to the internal standard as a function of
the drug concentration (C). This gives the following equation:
PAR= Slope · C+ Intercept. The slope and the intercept are
determined from the determined PAR and the nominal con-
centration of the drug. The unknown CBZ concentrations
are determined from this equation.
The precision of the method based on intraday variability
was determined by replicate analysis of the calibration stan-
dards in the same day. The reproducibility was taken as the
interday variability and was determined by replicate analysis
of the calibration standards in different days with one repli-
cate being analyzed each day. The relative standard devia-
tion values (RSD) were calculated from the ratios of the
standard deviation (SD) to the mean and expressed as
percentage.
The accuracy of the method was determined by comparing
practical amounts recovered from the control samples with ac-
tual values present in the samples (theoretical values). The
selectivity of the method was determined by examining theAU
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Figure 2 Representative chromatograms of carbamazepine showing
concentration (right). CBZ, carbamazepine; IS, internal standard.interference from the endogenous materials in rabbit plasma
or from the degradation products of the drug.
The limit of quantiﬁcation LOQ was taken as the lowest
concentration that can be accurately (relative error <20%
for biological samples and <2% for the in vitro samples)
and precisely determined (RSD <20% for biological samples
and <2% for the in vitro samples). The LOD for CBZ was
found to be 0.25 lg/ml and this result is in agreement with data
reported in Elizabeth et al. (2007). The drug is stable in liquid
preparation and the assay was not validated as stability indi-
cated (Srinivasa and Belorkar, 2010).3. Results and discussion
3.1. HPLC assay of CBZ
HPLC with UV detection was chosen as a simple, fast, and
effective separation method for the determination of CBZ
(Bhatti et al., 1998; Dasgupta et al., 1999; Ashy et al., 1986;
Raggi et al., 2000; Franceschi and Furlanut, 2005; Chelberg
et al., 1988; Hartley et al., 1986; Oh et al., 2006; Yoshida
et al., 2006; Elizabeth et al., 2007; Budakova et al., 2008;
Hemenway et al., 2010). In extensive preliminary experiments,
a series of aqueous mobile phases with different pH values in
combination with different organic modiﬁers were tested. Best
results were obtained when using methanol and water (50:50)
and adjusting the pH of the solution to 5, allowing adequate
separation of the drug and the internal standard using a C18
l-Bondapak column at a ﬂow-rate of 1.0 ml/min. In addi-
tion, depending on the weak plasma protein binding of both
drug and IS, methanol was used for protein precipitation
(1:1) in order to obtain satisfactory values for recovery of
CBZ and IS. The selected chromatographic conditions pro-
vided optimum resolution of CBZ and IS.AU
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Figure 3 Representative chromatograms of blank plasma (left) and the plasma spiked with 0.5 lg/ml of carbamazepine and its internal
standard (right).
Table 1 Validation parameters calculation for interday
(n= 3).
Nominal value
(lg/ml)
Recovered
conc. (lg/ml)
SD
(lg/ml)
RSD% % Recovery
0.5 0.493 0.012 2.5 98.59429
1 0.984 0.027 2.75 98.36924
2 2.00 0.054 2.69 100.0095
5 4.99 0.14 2.75 99.76992
10 9.97 0.24 2.43 99.72529
20 19.70 0.20 0.99 98.48914
40 40.2 0.21 0.53 100.4535
Table 2 Validation parameters calculation for intraday
(n= 3).
Nominal value
(lg/ml)
Recovered
conc. (lg/ml)
SD
(lg/ml)
RSD% % Recovery
0.5 0.49 0.018 3.7 97.87
1 1.0 0.11 3.4 100.23
2 2.07 0.025 1.21 103.58
5 5.04 0.092 1.82 100.85
10 9.8 0.29 2.94 97.53
20 19.9 0.21 1.06 99.28
40 39.95 1.06 2.65 99.9
32 H.A. Mowafy et al.Fig. 2 shows representative chromatograms of low and high
concentrations of CBZ in methanol. The CBZ and the IS were
eluted after 7.75 and 11.36 min, respectively. Using the chro-
matographic conditions described above, the selectivity was
further evidenced by the ability of the assay to separate the
drug and the internal standard from plasma samples without
interference from any endogenous material with a good sepa-
ration and resolution of their peaks. This is clearly indicated
from Fig. 3.
3.2. Method validation
The linearity of the assay method was evaluated by seven-point
standard curves; with concentration range selection of
(0.5–40 lg/ml) based on drug concentration. These standards
were analyzed in replicates of the range mentioned above.
Standard curves were constructed over a 6-week period to
determine the variability of the slopes and intercepts. The re-
sults show little day-to-day variability in the slopes and inter-
cepts. The mean (±standard deviation; SD) regression
equation for replicated calibration curves constructed on dif-
ferent days was determined using the least-squares linear
regression analysis method. Standard calibration curves re-
ﬂected good linearity of the assay in the concentration range
of 0.5–40 lg/ml. The linear regression of the calibration curve
produced an equation of (y= 0.2847x+ 0.0138), with a cor-
relation coefﬁcient of 0.9999 (R2).
The interday and intraday accuracies were expressed as the
closeness to the true value and are calculated as the percent
recovery related to the nominal values. Tables 1 and 2 present
the percentage of drug recovered relative to the nominal val-
ues. The recovered values were close to the true value suggest-
ing the accuracy of the assay. The % recoveries of CBZ was
ranged from 98.37% to 100.45% and 97.53% to 103.58%
for interday and intraday, respectively. These high values of
the % drug recovered reﬂect the accuracy of the assay method.
The interday and intraday precisions were measured as the
relative standard deviation (RSD) expressed as percentageover the concentration range of CBZ during the course of val-
idation. This is presented in Tables 1 and 2 for the interday
and intraday precisions. The results indicated an acceptable
precision for all concentrations assayed for both intraday
and interday samples. The RSD% of CBZ ranged from
0.53% to 2.75% and 1.06% to 3.7% for both interday and
intraday precisions, respectively. The low values of RSD% re-
ﬂect the precision of the assay method.
The LOQ for this method was found to be 0.5 lg/ml. This is
indicated from the precision and accuracy of such
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the concentration range (0.5–40 lg/ml) were acceptable (ICH
Guideline Q2 (R1), 2005). The speciﬁcity of the method with
regard to CBZ was ascertained by the absence of any co-eluted
or chromatographic interference peaks (Figs. 2 and 3).
4. Conclusion
The HPLC method developed in this article is rapid, sensitive,
and speciﬁc. The accuracy and precision of the method are
within the acceptable range (ICH Guideline Q2 (R1), 2005).
The simplicity of technique and the high sensitivity make this
technique particularly attractive for the quantiﬁcation of CBZ
in both solution and rabbit plasma. The method can also be
readily adapted to routine quality control analysis.Acknowledgment
This is work is fully supported by grant from National Plan for
Science, Technology and Innovation (08NAN307-2).
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